The Korean journal of pain · 2025
Effects of Transcranial Direct Current Stimulation on pain and pain-related outcomes: an umbrella review.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Tungushpayev Meiram, Viderman Dmitriy
Аннотация
BACKGROUND: This study examines Transcranial Direct Current Stimulation (tDCS), a non-invasive brain stimulation technique, as an alternative for pain management given the limitations of pharmacological treatments.
METHODS: We searched PubMed, Scopus, and the Cochrane Library for systematic reviews and meta-analyses (SRMAs) on the efficacy of tDCS across pain-related conditions. Outcomes included treatment regimens, mechanisms, effects, and adverse events. Methodological quality was assessed with AMSTAR-2 and evidence levels with GRADE.
RESULTS: Forty-one SRMAs were included. Positive effects were observed across 14 pain-related conditions, including 10 pain mechanism-specific outcomes and 6 other pain-related outcomes. Analgesic effects were reported in the short-, mid-, and long-term (up to 4 weeks), especially with stimulation over the primary motor cortex.
CONCLUSIONS: Our findings suggest that tDCS might be effective for fibromyalgia, migraine, and neuropathic pain associated with spinal cord injury and stroke. However, further evidence is needed for chronic orofacial pain, multiple sclerosis, knee osteoarthritis, central post-stroke pain, intra-abdominal pain, and phantom limb pain. As most of the evidence stems from reviews with "critically low" quality, more high-quality studies are needed in the future.
METHODS: We searched PubMed, Scopus, and the Cochrane Library for systematic reviews and meta-analyses (SRMAs) on the efficacy of tDCS across pain-related conditions. Outcomes included treatment regimens, mechanisms, effects, and adverse events. Methodological quality was assessed with AMSTAR-2 and evidence levels with GRADE.
RESULTS: Forty-one SRMAs were included. Positive effects were observed across 14 pain-related conditions, including 10 pain mechanism-specific outcomes and 6 other pain-related outcomes. Analgesic effects were reported in the short-, mid-, and long-term (up to 4 weeks), especially with stimulation over the primary motor cortex.
CONCLUSIONS: Our findings suggest that tDCS might be effective for fibromyalgia, migraine, and neuropathic pain associated with spinal cord injury and stroke. However, further evidence is needed for chronic orofacial pain, multiple sclerosis, knee osteoarthritis, central post-stroke pain, intra-abdominal pain, and phantom limb pain. As most of the evidence stems from reviews with "critically low" quality, more high-quality studies are needed in the future.